China has brought significant reforms in its regulatory system for pharmaceutical industry and clinical trials. In its continuous drive to improve the system, recently China’s Food and Drug Administration (CFDA) announced a major overhaul of its medical device regulations as well. To the current regulations, China has made significant changes. Summarily, 12 articles were newly […]
Read More →
Foot ulcers refer to a patch of broken-down skin usually on the lower leg or feet. In diabetics, when blood sugar levels are high or fluctuate regularly, skin that would normally heal may not properly repair itself because of nerve damage. therefore start a foot ulcer. It occurs in 15% of people with diabetes and precedes […]
Read More →
Glomerulonephritis (GN) is a serious kidney disorder that can lead to end-stage renal disease (ESRD), serious morbidity, or death. Worldwide, IgA Nephropathy (Berger disease) is the most common cause of GN. IgA nephropathy is an autoimmune disease and is one of the most common kidney diseases, other than those caused by diabetes or high blood pressure. […]
Read More →
China is the largest clinical trial market in Asia and the 5th largest in the world. In recent years there was a remarkable increase in Phase I-III clinical trials. Understandably, there must be something significant happening, which brought this change. The recent changes in policies and regulations in China have brought a lot of cheer from […]
Read More →
The Philippines is a country with a large population and a wide network of hospitals, medical centers, and healthcare professionals, making it a fertile platform for conducting clinical trials. In clinical trials, the Philippines ranks number three in Southeast countries (US NIH) and ranks number eight worldwide (European Medicines Agency reports). Clinical trial statistics in […]
Read More →
Pancreatitis, inflammation of the pancreas, is the leading cause of GI-related hospitalizations in the USA and many other countries, with a medical condition requiring emergent care. The yearly incidence of Acute Pancreatitis in the United States and western countries is approximately 70-80 new cases per 100,000 population and has increased over the last decade. In […]
Read More →
Australia has the world’s best researchers and health professionals, a world-class research infrastructure, and high standards for clinical trial conduct, which leads to quality, increased speed, and high confidence in the results. Note: This article was last updated in Oct 2024. They have quality research facilities, an efficient ethical and regulatory framework, a diverse participant […]
Read More →Malaysia is one of the world’s most popular countries for coastal tourism, known for its culinary sensations, beautiful beaches, idyllic islands, and national parks. Conducting clinical trials in Malaysia offers a diverse patient population, well-established healthcare infrastructure, favorable regulatory environment, and cost-effective research opportunities. Note: This article was updated in May, 2023 Malaysia owns a large […]
Read More →
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood that interfere with normal blood cells. It’s sometimes called acute myelocytic, myelogenous, or granulocytic leukemia. Causes of AML The causes of AML remain largely […]
Read More →
Vietnam, known for its tourism destination, is also a destination for clinical trials and research. With a sizeable population of 85 million, Vietnam offers a vast pool of participants, healthcare professionals, and strong doctor-patient relationships, which result in a greater retention rate. Clinical Trials in Vietnam In the last few years, Vietnam has been a […]
Read More →